Predictive medicine

Prenatal Testing & Newborn Screening Market Research Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 16, 2021
General Health, Women, Consumer, Health, Genetics, Medicine, Clinical medicine, Branches of biology, Medical tests, Midwifery, Prenatal testing, Newborn screening, Down syndrome, Screening, Predictive medicine, Elective genetic and genomic testing

The "Prenatal Testing & Newborn Screening Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Prenatal Testing & Newborn Screening Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The prenatal testing and newborn screening tests market consists of sales of prenatal testing and newborn screening tests services and related goods by entities (organizations, sole traders and partnerships) that provide prenatal testing and newborn screening tests, which help to determine various genetic and chromosomal diseases, to provide timely medical or surgical treatment of a condition before or after birth.
  • The use of machine learning and artificial intelligence is gradually gaining popularity in the prenatal testing and newborn screening market.
  • The prenatal testing and newborn screening market covered in this report is segmented by diagnostic type into non-invasive; invasive.

Genetic Technologies Continues to Break New Ground as it Advances Development of its Predictive Risk Test for Multiple Cancers & Morbidities

Retrieved on: 
Friday, July 9, 2021
Health sciences, Articles, Actuarial science, Academic disciplines, Cancer, Preventive healthcare, Risk, Predictive medicine

Predictive Panel Risk Test to cover six common cancers which account for ~70% of annual morbidities.

Key Points: 
  • Predictive Panel Risk Test to cover six common cancers which account for ~70% of annual morbidities.
  • The Predictive Risk Test combines clinical patient information with genetic information to maximize test accuracy, leveraging the Companys foundational IP (US Patent 7,127,355 Methods for Genetic Analysis) to enable the best health risk assessment test available.
  • The overall strategy for the Companys Predictive Risk Test is focused on precise risk assessments for the most common preventable diseases.
  • As a group, the diseases covered by the Predictive Risk Test account for approximately 30% of annual mortality.

Insights on the Genetic Testing Global Market to 2026 - Key Motivators, Restraints and Opportunities - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 1, 2021
Biotechnology, Health, Genetics, Science, Research, Branches of biology, Medicine, Medical genetics, Clinical medicine, Alternatives to animal testing, Genetic testing, Genetic disorder, Cancer, Human genetics, Predictive medicine, Genetic discrimination

The global genetic testing market is growing at a significant CAGR during the forecast period.

Key Points: 
  • The global genetic testing market is growing at a significant CAGR during the forecast period.
  • Genetic testing is a medical test that is used for the identification of mutations in genes or chromosomes.
  • The global genetic testing market is projected to considerably grow in the upcoming year due to the prevalence of genetic disorders, cancer, and chronic disease.
  • Moreover, the adoption of (DTC) direct-to-consumer genetic testing kits in countries such as the US, China, and Japan, is increasing rapidly.

Worldwide Genetic Testing Industry to 2027 - Advancements in Genetic Testing Techniques is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, February 8, 2021
Health, Genetics, Branches of biology, Medicine, Medical genetics, Clinical medicine, Medical tests, Alternatives to animal testing, Genetic testing, Predictive testing, Prenatal testing, Elective genetic and genomic testing, Predictive medicine

There are various types of genetic testing and several methods such as cytogenetic testing, biochemical testing, molecular testing, and chromosome analysis used to determine changes in a person's chromosomes, genes, or proteins.

Key Points: 
  • There are various types of genetic testing and several methods such as cytogenetic testing, biochemical testing, molecular testing, and chromosome analysis used to determine changes in a person's chromosomes, genes, or proteins.
  • Different types of genetic testing are done for different reasons such as presymptomatic and predictive testing, carrier testing, prenatal testing, and newborn screening.
  • In addition, advancements in genetic testing techniques are expected to boost the market growth during the forecast period.
  • By type, the market is categorized into predictive & presymptomatic testing, carrier testing, prenatal & newborn testing, diagnostic testing, pharmacogenomic testing, and others.

Progenity Reaches Two Million Test Milestone

Retrieved on: 
Wednesday, January 20, 2021
Branches of biology, Medical specialties, Clinical medicine, Medical genetics, Medical tests, Biotechnology, Molecular diagnostics, Prenatal testing, Genetic disorder, Cystic fibrosis, Predictive medicine, Genetic counseling

This notable milestone comes as Progenity celebrates the ten-year anniversary of the companys founding.

Key Points: 
  • This notable milestone comes as Progenity celebrates the ten-year anniversary of the companys founding.
  • Progenity was established in 2011 as a womens health molecular diagnostics company offering a genetic carrier test for the detection of cystic fibrosis.
  • Today, the company has commercialized a portfolio of diagnostic products, including the Preparent Carrier Test for hereditary genetic diseases; the Innatal Prenatal Screen for chromosomal disorders; the Riscover Hereditary Cancer test, and the Resura Prenatal Test , which provides noninvasive prenatal screening for monogenic diseases.
  • Achieving the milestone of two million tests performed in the Progenity laboratory demonstrates our strong commercial capabilities in bringing to market and sustaining leading-edge diagnostic products, said Harry Stylli, PhD, CEO, chairman of the board and co-founder of Progenity.

Global Genetic Testing Market Outlook to 2022 Featuring Abbott Laboratories, Roche Diagnostics, Myriad Genetics, Thermo Fisher Scientific, Hologic, Cepheid, Agilent Technologies, and QIAGEN

Retrieved on: 
Wednesday, December 16, 2020
Medicine, Branches of biology, Clinical medicine, Medical genetics, Alternatives to animal testing, Genetic testing, Rare diseases, Prenatal testing, Newborn screening, Elective genetic and genomic testing, Predictive medicine

DUBLIN, Dec. 16, 2020 /PRNewswire/ -- The "Global Genetic Testing Market Outlook 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 16, 2020 /PRNewswire/ -- The "Global Genetic Testing Market Outlook 2022" report has been added to ResearchAndMarkets.com's offering.
  • "Global Genetic Testing Market Outlook 2022" provides a detailed analysis of the genetic testing market.
  • Growing awareness about genetic testing, technological advances in genetic sequencing, and rising incidences of genetic diseases especially cancer are some of the major factors propelling the genetic testing market.
  • Based on application, the genetic testing market is divided into Diagnostic Testing, Newborn Screening, Prenatal Testing, Carrier Screening, and Others.

Global Genetic Testing Market Report 2020: Updated Current and Future Perspectives of the Market to 2022 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 9, 2020
Health, Genetics, Branches of biology, Medicine, Clinical medicine, Medical genetics, Medical tests, Alternatives to animal testing, Genetic testing, Prenatal testing, Elective genetic and genomic testing, Predictive medicine

"Global Genetic Testing Market Outlook 2022" provides a detailed analysis of the genetic testing market.

Key Points: 
  • "Global Genetic Testing Market Outlook 2022" provides a detailed analysis of the genetic testing market.
  • Growing awareness about genetic testing, technological advances in genetic sequencing, and rising incidences of genetic diseases especially cancer are some of the major factors propelling the genetic testing market.
  • Based on application, the genetic testing market is divided into Diagnostic Testing, Newborn Screening, Prenatal Testing, Carrier Screening, and Others.
  • The report provides a current and forecasted market for each of the genetic conditions of Genetic Testing.

Genomic testing in the U.S. workplace

Retrieved on: 
Thursday, November 5, 2020
Branches of biology, Medicine, Medical genetics, Clinical medicine, Alternatives to animal testing, Genetic testing, Jackson Laboratory, Human genetics, Predictive medicine

One potential means of enhancing employee health and lowering health care-related costs is genomic testing.

Key Points: 
  • One potential means of enhancing employee health and lowering health care-related costs is genomic testing.
  • Some employers are already offering voluntary workplace genomic testing through their health plans; others are considering adding this testing to their list of medical benefits.
  • Consequently, says Charles Lee, Ph.D. , FACMG, professor and scientific director of The Jackson Laboratory (JAX) for Genomic Medicine, workplace genomic testing raises substantial legal and policy concerns, including privacy of genetic information.
  • Where previous ELSI studies of genetic testing have focused on the negative consequences of results from genetic tests conducted as part of medical treatment for a specific disease or condition, this study addresses workplace genetic testing offered by employers and conducted by third-party genomic testing companies for preventive health as a benefit to employees.

Genetic Testing Market to Reach $21.26 Bn, Globally, by 2027 at 10.1% CAGR: Allied Market Research

Retrieved on: 
Monday, October 19, 2020
Branches of biology, Medicine, Clinical medicine, Medical tests, Medical genetics, Genetic testing, Predictive testing, Personalized medicine, Carrier testing, Elective genetic and genomic testing, Predictive medicine

- Increase in incidences of genetic disorders and cancer, surge in awareness & acceptance of personalized medicines, and advancements in genetic testing techniquesfuel the growth of the global genetic testing market

Key Points: 
  • - Increase in incidences of genetic disorders and cancer, surge in awareness & acceptance of personalized medicines, and advancements in genetic testing techniquesfuel the growth of the global genetic testing market
    PORTLAND, Ore., Oct. 19, 2020 /PRNewswire/ -- Allied Market Research published a report, titled," Genetic Testing Market by Type (Predictive & Presymptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Others), Technology (Cytogenetic Testing, Biochemical Testing, and Molecular Testing), Application (Cancer diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, and Others): Global Opportunity Analysis and Industry Forecast, 20202027" According to the report, the global genetic testing industry was estimated at$12.68 billion in 2019, and is expected to reach $ 21.26 billion by 2027, registering a CAGR of 10.1% from 2020 to 2027.
  • Download Detailed COVID-19 Impact Sample Report at: https://www.alliedmarketresearch.com/request-for-customization/5241?reqf...
    Increase in incidences of genetic disorders and cancer, surge in awareness & acceptance of personalized medicines, and advancements in genetic testing techniquesfuel the growth of the global genetic testing market.
  • Based on type, the prenatal and newborn testing segment accounted for nearly one-third of the global genetic testing market revenue in 2019 and is expected to maintain the lion's share till 2027.
  • This is due to the factors such as surge in awareness associated with genetic testing, and rise in healthcare expenditure.

Genetic Technologies Announces US Sales Have Commenced via Online Health Platform

Retrieved on: 
Friday, September 11, 2020
Articles, Health informatics, Assistive technology, Telehealth, Preventive healthcare, Health Insurance Portability and Accountability Act, Risk assessment, Predictive medicine

The secure, Health Insurance Portability and Accountability Act (HIPAA)-compliant health platform enables women meeting the required criteria in the United States to purchase the test and receive results via telehealth clinicians.

Key Points: 
  • The secure, Health Insurance Portability and Accountability Act (HIPAA)-compliant health platform enables women meeting the required criteria in the United States to purchase the test and receive results via telehealth clinicians.
  • Our goal was always to give individuals unprecedented access to their own genetic data to understand their health risks and take a more proactive approach to prevention, said Genetic Technologies CEO Dr George Muchnicki.
  • Genetic Technologies plans on launching its own online, telehealth-supported system to deliver its GeneType products to Australians.
  • Genetic Technologies has capacity for Covid-19 testing and is developing a pipeline of risk assessment products.